2
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T22180 | 3F8 | 3F 8,3F-8 | GSK-3 |
3F8 is a selective GSK-3β inhibitor that can be used as a new tool and potential therapeutic candidate compound for GSK3-related diseases, and can be used in the study of neurological disorders and cancer. | |||
T77448 | Naxitamab | Naxitamab-gqgk,Humanized 3F8,Hu3F8 | Others |
Naxitamab (Hu3F8) is a humanized monoclonal antibody against GD2 (hu3F8). Naxitamab has antitumor activity and can be used to study neuroblastoma, osteosarcoma, and other GD2-positive cancers. |